Skip to main content

Reimbursement

2022 Look Ahead
By Emily Olsen | 02:18 pm | January 12, 2022
Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue this year, and that the push toward interoperability will be critical for the space.
By HIMSS TV | 09:35 am | December 03, 2021
This week's top stories include baby tech company Owlet pulling its connected-sock wearables following an FDA warning letter, and TeamHealth's victory in a lawsuit accusing UnitedHealthcare of engaging in unfair reimbursement practices.
By HIMSS TV | 07:00 am | November 16, 2021
Gravie Pay wants healthcare billing without "gotchas," says Ben Simmons, VP of insurance at Gravie.
By Emily Olsen | 12:45 pm | October 13, 2021
Around two million people receive coverage through Massachusetts' Medicaid program.
By HIMSS TV | 10:04 am | September 24, 2021
This week's top stories include projections that hospitals could lose $54 billion this year, Apple looking to add a feature that could detect potential mental illness, and a link found between ransomware and increased mortality rate.
By Mallory Hackett | 12:51 pm | August 19, 2021
The company has $6 million in seed funding from Lightspeed Venture Partners, Define Ventures and Qiming Venture Partners USA.   
By Emily Olsen | 12:53 pm | August 05, 2021
Also: Kenshō Health, which helps patients find holistic healthcare providers, raised another $3.5 million.
By Emily Olsen | 06:44 pm | August 02, 2021
Researchers found patients who used reSET-O along with buprenorphine and counseling lowered their healthcare costs by $2,385 per person in the six months after they started using the app, compared with the six months before.
By HIMSS TV | 09:39 am | June 11, 2021
This week's top stories include UnitedHealthcare re-examining a policy that allows it to deny ER claims, Apple unveiling walking stability assessments for the iPhone, and Mount Sinai catering to patients with limited English proficiency.
By Dave Muoio | 04:04 pm | April 01, 2021
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.